- Patent Title: Crystalline salts of peptide epoxyketone immunoproteasome inhibitor
-
Application No.: US17953935Application Date: 2022-09-27
-
Publication No.: US11891383B2Publication Date: 2024-02-06
- Inventor: Henry Johnson , Evan Lewis , Sean Dalziel , Dustin McMinn
- Applicant: KEZAR LIFE SCIENCES
- Applicant Address: US CA South San Francisco
- Assignee: KEZAR LIFE SCIENCES
- Current Assignee: KEZAR LIFE SCIENCES
- Current Assignee Address: US CA South San Francisco
- Agency: MARSHALL, GERSTEIN & BORUN LLP
- The original application number of the division: US17066556 2020.10.09
- Main IPC: C07D413/12
- IPC: C07D413/12 ; C07D303/32 ; A61P29/00 ; A61P37/02 ; A61P1/04 ; A61P3/10 ; A61P5/14 ; A61P7/04 ; A61P7/06 ; A61P9/10 ; A61P11/06 ; A61P13/12 ; A61P17/00 ; A61P17/06 ; A61P19/02 ; A61P21/00 ; A61P21/04 ; A61P25/00 ; A61P31/04 ; A61P37/00 ; A61P37/06 ; A61P37/08 ; A61P43/00
Abstract:
Provided herein is a peptide epoxyketone immunoproteasome inhibitor, crystal forms, salts, and processes for making the same, and formulations thereof.
Information query
